一种基于真实世界的数据的方法,以优化烧伤患者的埃诺沙巴林剂量
Babajide Shenkoya1, Venkata Yellepeddi2,3, Ann Marie B Prazak4
1Center for Translational Medicine, Department of Pharmacy Practice, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.
British journal of clinical pharmacology
|November 24, 2025
概括
使用人口药动力学模型优化烧伤患者的埃诺沙巴林剂量,与标准方程方法相比,显著改善了目标抗Xa水平,特别是对于那些烧伤表面面积较大的人来说.
科学领域:
- 药理动力学和药理动力学
- 药物剂量优化 药物剂量优化
- 烧伤患者管理管理
背景情况:
- 在烧伤患者中服用埃诺沙的剂量是复杂的,因为改变了生理学.
- 目前以方程为基础的剂量往往无法达到治疗目标.
研究的目的:
- 在烧伤患者中开发埃诺沙巴林的人口药理学 (PK) 模型.
- 评估基于当前方程 (EQ) 的剂量有效性.
- 建议一个优化的埃诺沙巴林剂量方案.
主要方法:
- 分析了408名烧伤患者的现实数据.
- 开发一个单间PK模型.
- 模拟EQ剂量与基于模型的剂量.
主要成果:
- 只有56%的患者在EQ剂量时达到目标抗Xa水平.
- 燃烧表面总面积和体重受埃诺沙巴林PK的影响.
- 基于模型的剂量提高了超过70%的目标实现.
结论:
- 在烧伤患者中成功开发了一种人群PK模型,用于氧沙.
- 基于模型的剂量增强了早期预防性目标的实现.
- 这一策略优化了高风险烧伤患者的埃诺沙巴林使用.
相关概念视频
Dosage Regimens: Designs and Approaches
246
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
246
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
208
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
208
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
198
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
198
Dosage Regimens: Partial Pharmacokinetic Parameters
138
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
138
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
220
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
220
Dosage Regimen: Individualization
156
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
156


